Endothelin-1-like immunoreactivity in a new rodent model of spontaneous hypertension

American Journal of Hypertension

Volumn 11, Issue 7, 1998, Pages 866-869

  Gulati, Anil ^a   Artwohl, James E ^a   Kumar, Ashok ^a   Gao, Xiao Pei ^a   Rubinstein, Israel ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Endothelin; Essential hypertension; Genetic hypertension; Hamster; Radioimmunoassay

Indexed keywords

ENDOTHELIN 1;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; HAMSTER; HEART; HEREDITARY HYPERTENSION; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TISSUE LEVEL;

ANIMALS; BRAIN; CRICETINAE; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; HYPERTENSION; KIDNEY; LIVER; LUNG; MALE; MYOCARDIUM; RADIOIMMUNOASSAY; SPLEEN; TISSUE DISTRIBUTION;

EID: 0032126062     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00047-8     Document Type: Article

References (25)

1. 1. Schiffrin EL: Endothelin: potential role in hypertension and vascular hypertrophy (Brief Review). Hypertension 1995;25:1135-1143.
2. 2. Lerman A, Hildebrand FL Jr, Arhus LL, Burnett JC Jr: Endothelin has biological actions at pathophysiological concentrations. Circulation 1991;83:1808-1814.
3. 3. Masaki T, Kimura S, Yanagisawa M, Goto K: Molecular and cellular mechanism of endothelin regulation. Implications for vascular function. Circulation 1991;84: 1457-1468.
4. 4. Suzuki N, Miyauchi T, Tomobe Y, et al: Plasma concentrations of endothelin-1 in spontaneously hypertensive rats and DOCA-salt hypertensive rats. Biochem Biophys Res Commun 1990;167:941-947.
5. 5. Shichiri M, Hirata Y, Ando K, et al: Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 1990;15:493-496.
6. 6. Vemulapalli S, Chiu PJ, Rivelli M, et al: Modulation of circulating endothelin levels in hypertension and endotoxemia in rats. J Cardiovasc Pharmacol 1991;18:895-903.
7. 7. Larivière R, Deng LY, Day R, et al: Increased endothelin-1 gene expression in the endothelium of coronary arteries and endocardium in the DOCA-salt hypertensive rat. J Mol Cell Cardiol 1995;27:2123-2131.
8. 8. Sventek P, Turgeon A, Garcia R, Schiffrin EL: Vascular and cardiac overexpression of endothelin-1 gene in 1-kidney, one clip Goldblatt hypertensive rats but only in the late phase of 2-kidney, 1 clip Goldblatt hypertension. J Hypertens 1996;14:57-64.
9. G-nitro-L-arginine methyl ester: correlation with topography of vascular endothelin-1 gene expression. Hypertension 1996;28:188-195.
10. 10. Rubinstein I, Houmsse M, Davis RG, Vishwanatha JK: Tissue angiotensin I-converting enzyme activity in spontaneously hypertensive hamsters. Biochem Biophys Res Commun 1992;183:1117-1123.
11. 11. Suzuki H, Noda Y, Gao X-P, et al: Encapsulation of VIP into liposomes restores vasorelaxation in hypertension in situ. Am J Physiol 1996;271:H282-H287.
12. 12. Séjourné F, Rubinstein I, Suzuki H, Alkan-Önyüksel H: Development of a novel bioactive formulation of vasoactive intestinal peptide in sterically stabilized liposomes. Pharm Res 1997;14:362-365.
13. 13. Thomas CL, Artwohl JE, Suzuki H, et al: Initial characterization of hamsters with spontaneous hypertension. Hypertension 1997;30(part 1):301-304.
14. 14. Boric MP, Donoso V, Fournier A, et al: Endothelin reduces microvascular blood flow by acting on arterioles and venules of the hamster cheek pouch. Eur J Pharmacol 1990;190:123-133.
15. 15. Weglicki WB, Phillips TM, Freedman AM, et al: Magnesium deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem 1992;110:169-173.
16. 16. Bolger GT, Berry R, Liard F, et al: Cardiac responses and binding sites for endothelin in normal and cardiomyopathic hamsters. J Pharmacol Exp Ther 1992;260: 1314-1322.
17. 17. Seldeslagh KA, Lauweryns JM: Endothelin in normal lung tissue of newborn mammals: immunocytochemical distribution and co-localization with serotonin and calcitonin gene-related peptide. J Histochem Cytochem 1993;41:1495-1502.
18. 18. Iyer RS, Singh G, Rebello S, et al: Changes in the concentration of endothelin-1 during development of hypertensive rats. Pharmacology 1995;51:96-104.
19. B receptors in venous and arterial smooth muscle. Eur J Pharmacol 1995;287:279-285.
20. 20. Mayhan WG, Rubinstein I: Response of hamster cheek pouch microcirculation to endothelin and endothelin receptor antagonists. Int J Microcirc 1995;15:48-52.
21. 21. Wagner OF, Christ G, Wojta J, et al: Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 1992;267:16066-16068.
22. 22. Khraibi AA, Heublein DM, Knox FG, Burnett JC Jr: Increased plasma level of endothelin-1 in the Okamoto spontaneously hypertensive rat. Mayo Clin Proc 1993; 68:42-46.
23. 23. Kohno M, Murakawa K, Horio T, et al: Plasma immunoreactive endothelin-1 in experimental malignant hypertension. Hypertension 1991;18:93-100.
24. 24. Dohi Y, Lüscher TF: Endothelin in hypertensive resistance arteries: intraluminal and extraluminal dysfunction. Hypertension 1991;18:543-549.
25. 25. Hirata Y, Hayakawa H, Suzuki E, Omata M: Does endothelin work as an intrarenal mechanism to alter pressure natriuresis in spontaneously hypertensive rats? J Hypertens 1994;12:251-257.